Equities

Daito Pharmaceutical Co Ltd

Daito Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,138.00
  • Today's Change-13.00 / -0.60%
  • Shares traded11.20k
  • 1 Year change+11.41%
  • Beta0.8091
Data delayed at least 20 minutes, as of Nov 13 2024 02:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of May 31 2024202420232022
OPERATIONS
Net income4,2185,0766,720
Depreciation/depletion3,6593,8703,313
Non-Cash items(418)30(174)
Cash taxes paid, supplemental1,2652,4111,924
Cash interest paid, supplemental40139.00
Changes in working capital(2276)(4820)(5488)
Total cash from operations5,1834,1564,371
INVESTING
Capital expenditures(6276)(5556)(4733)
Other investing and cash flow items, total346(10)333
Total cash from investing(5930)(5566)(4400)
FINANCING
Financing cash flow items(1)(2)80
Total cash dividends paid(907)(931)(660)
Issuance (retirement) of stock, net(1176)1921,514
Issuance (retirement) of debt, net1,9011,35755
Total cash from financing(183)616989
NET CHANGE IN CASH
Foreign exchange effects512048
Net change in cash(879)(774)1,008
Net cash-begin balance/reserved for future use3,6074,3813,372
Net cash-end balance/reserved for future use2,7273,6074,381
SUPPLEMENTAL INCOME
Depreciation, supplemental3,6593,8703,313
Cash interest paid, supplemental40139.00
Cash taxes paid, supplemental1,2652,4111,924
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.